543 related articles for article (PubMed ID: 14517280)
1. Influence of the RNA-binding protein HuR in pVHL-regulated p53 expression in renal carcinoma cells.
Galbán S; Martindale JL; Mazan-Mamczarz K; López de Silanes I; Fan J; Wang W; Decker J; Gorospe M
Mol Cell Biol; 2003 Oct; 23(20):7083-95. PubMed ID: 14517280
[TBL] [Abstract][Full Text] [Related]
2. von Hippel-Lindau tumor suppressor gene-dependent mRNA stabilization of the survival factor parathyroid hormone-related protein in human renal cell carcinoma by the RNA-binding protein HuR.
Danilin S; Sourbier C; Thomas L; Rothhut S; Lindner V; Helwig JJ; Jacqmin D; Lang H; Massfelder T
Carcinogenesis; 2009 Mar; 30(3):387-96. PubMed ID: 19056930
[TBL] [Abstract][Full Text] [Related]
3. von Hippel-Lindau protein-mediated repression of tumor necrosis factor alpha translation revealed through use of cDNA arrays.
Galbán S; Fan J; Martindale JL; Cheadle C; Hoffman B; Woods MP; Temeles G; Brieger J; Decker J; Gorospe M
Mol Cell Biol; 2003 Apr; 23(7):2316-28. PubMed ID: 12640117
[TBL] [Abstract][Full Text] [Related]
4. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
5. RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation.
Mazan-Mamczarz K; Galbán S; López de Silanes I; Martindale JL; Atasoy U; Keene JD; Gorospe M
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8354-9. PubMed ID: 12821781
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of p53 expression in keratinocytes by the bioflavonoid apigenin is associated with RNA-binding protein HuR.
Tong X; Pelling JC
Mol Carcinog; 2009 Feb; 48(2):118-29. PubMed ID: 18680106
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein.
Li Z; Na X; Wang D; Schoen SR; Messing EM; Wu G
J Biol Chem; 2002 Feb; 277(7):4656-62. PubMed ID: 11739384
[TBL] [Abstract][Full Text] [Related]
8. Translational control of cytochrome c by RNA-binding proteins TIA-1 and HuR.
Kawai T; Lal A; Yang X; Galban S; Mazan-Mamczarz K; Gorospe M
Mol Cell Biol; 2006 Apr; 26(8):3295-307. PubMed ID: 16581801
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin A2-mediated stabilization of p21 mRNA through an ERK-dependent pathway requiring the RNA-binding protein HuR.
Yang X; Wang W; Fan J; Lal A; Yang D; Cheng H; Gorospe M
J Biol Chem; 2004 Nov; 279(47):49298-306. PubMed ID: 15371446
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma.
Turcotte S; Desrosiers RR; Beliveau R
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F338-48. PubMed ID: 14583436
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 in renal carcinoma cells is independent of pVHL.
Stickle NH; Cheng LS; Watson IR; Alon N; Malkin D; Irwin MS; Ohh M
Mutat Res; 2005 Oct; 578(1-2):23-32. PubMed ID: 15998523
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel VHL target genes and relationship to hypoxic response pathways.
Maina EN; Morris MR; Zatyka M; Raval RR; Banks RE; Richards FM; Johnson CM; Maher ER
Oncogene; 2005 Jun; 24(28):4549-58. PubMed ID: 15824735
[TBL] [Abstract][Full Text] [Related]
13. Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness.
He X; Wang J; Messing EM; Wu G
Oncogene; 2011 Feb; 30(5):535-47. PubMed ID: 20871634
[TBL] [Abstract][Full Text] [Related]
14. VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma.
Razafinjatovo CF; Stiehl D; Deininger E; Rechsteiner M; Moch H; Schraml P
Oncotarget; 2017 Feb; 8(6):10199-10212. PubMed ID: 28052007
[TBL] [Abstract][Full Text] [Related]
15. Novel binding of HuR and poly(C)-binding protein to a conserved UC-rich motif within the 3'-untranslated region of the androgen receptor messenger RNA.
Yeap BB; Voon DC; Vivian JP; McCulloch RK; Thomson AM; Giles KM; Czyzyk-Krzeska MF; Furneaux H; Wilce MC; Wilce JA; Leedman PJ
J Biol Chem; 2002 Jul; 277(30):27183-92. PubMed ID: 12011088
[TBL] [Abstract][Full Text] [Related]
16. HADHB, HuR, and CP1 bind to the distal 3'-untranslated region of human renin mRNA and differentially modulate renin expression.
Adams DJ; Beveridge DJ; van der Weyden L; Mangs H; Leedman PJ; Morris BJ
J Biol Chem; 2003 Nov; 278(45):44894-903. PubMed ID: 12933794
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor.
Knebelmann B; Ananth S; Cohen HT; Sukhatme VP
Cancer Res; 1998 Jan; 58(2):226-31. PubMed ID: 9443397
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.
Tran H; Maurer F; Nagamine Y
Mol Cell Biol; 2003 Oct; 23(20):7177-88. PubMed ID: 14517288
[TBL] [Abstract][Full Text] [Related]
19. Loss of the von Hippel Lindau tumor suppressor disrupts iron homeostasis in renal carcinoma cells.
Alberghini A; Recalcati S; Tacchini L; Santambrogio P; Campanella A; Cairo G
J Biol Chem; 2005 Aug; 280(34):30120-8. PubMed ID: 15985433
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD83 is regulated by HuR via a novel cis-active coding region RNA element.
Prechtel AT; Chemnitz J; Schirmer S; Ehlers C; Langbein-Detsch I; Stülke J; Dabauvalle MC; Kehlenbach RH; Hauber J
J Biol Chem; 2006 Apr; 281(16):10912-25. PubMed ID: 16484227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
